Topoisomerase Iialpha Predicts Survival in Breast Cancer Treated with Neoadjuvant Anthracyclin Based Chemotherapy

被引：0
|
作者：
Elghobashy, M. [1 ]
Sharma, G. [2 ]
Gahlaut, R. [3 ]
van den Berg, A. [3 ]
Fatayer, H. [3 ]
Sharma, N. [3 ]
Dall, B. [3 ]
Velikova, G. [3 ]
Perren, T. [3 ]
Dodwell, D. [3 ]
Lansdown, M. [3 ]
Shaaban, A. M. [4 ]
机构：
[1] KEHS, Birmingham, W Midlands, England
[2] Univ Windsor, Sch Med, Windsor, ON N9B 3P4, Canada
[3] St James Univ Hosp, Leeds, W Yorkshire, England
[4] Queen Elizabeth Hosp Birmingham, Birmingham, W Midlands, England
来源：
JOURNAL OF PATHOLOGY | 2015年 / 237卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S29 / S29
页数：1
相关论文
共 50 条
  • [1] Nutritional Risk Index Predicts Survival in Patients With Breast Cancer Treated With Neoadjuvant Chemotherapy
    Chen, Li
    Qi, Yihang
    Kong, Xiangyi
    Su, Zhaohui
    Wang, Zhongzhao
    Wang, Xiangyu
    Du, Yaying
    Fang, Yi
    Li, Xingrui
    Wang, Jing
    FRONTIERS IN NUTRITION, 2022, 8
  • [2] Tumor Response Ratio Predicts Overall Survival in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy
    Miller, Marian
    Ottesen, Rebecca A.
    Niland, Joyce C.
    Kruper, Laura
    Chen, Steven L.
    Vito, Courtney
    ANNALS OF SURGICAL ONCOLOGY, 2014, 21 (10) : 3317 - 3323
  • [3] Tumor Response Ratio Predicts Overall Survival in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy
    Marian Miller
    Rebecca A. Ottesen
    Joyce C. Niland
    Laura Kruper
    Steven L. Chen
    Courtney Vito
    Annals of Surgical Oncology, 2014, 21 : 3317 - 3323
  • [4] In situ immune response after neoadjuvant chemotherapy for breast cancer predicts survival
    Ladoire, Sylvain
    Mignot, Gregoire
    Dabakuyo, Sandrine
    Arnould, Laurent
    Apetoh, Lionel
    Rebe, Cedric
    Coudert, Bruno
    Martin, Francois
    Bizollon, Marie Helene
    Vanoli, Andre
    Coutant, Charles
    Fumoleau, Pierre
    Bonnetain, Franck
    Ghiringhelli, Francois
    JOURNAL OF PATHOLOGY, 2011, 224 (03): : 389 - 400
  • [5] In Situ Immune Response after Neoadjuvant Chemotherapy for Breast Cancer Predicts Survival
    Ladoire, S.
    Coudert, B.
    Fumoleau, P.
    Arnould, L.
    Ghiringhelli, F.
    CANCER RESEARCH, 2010, 70
  • [6] Changes of topoisomerase IIα expression in breast tumors after neoadjuvant chemotherapy predicts relapse-free survival
    Tinari, N
    Lattanzio, R
    Natoli, C
    Cianchetti, E
    Angelucci, D
    Ricevuto, E
    Ficorella, C
    Marchetti, P
    Alberti, S
    Piantelli, M
    Iacobelli, S
    CLINICAL CANCER RESEARCH, 2006, 12 (05) : 1501 - 1506
  • [7] Low pan-immune-inflammation-value predicts better chemotherapy response and survival in breast cancer patients treated with neoadjuvant chemotherapy
    Sahin, Ahmet Bilgehan
    Cubukcu, Erdem
    Ocak, Birol
    Deligonul, Adem
    Orhan, Sibel Oyucu
    Tolunay, Sahsine
    Gokgoz, Mustafa Sehsuvar
    Cetintas, Sibel
    Yarbas, Gorkem
    Senol, Kazim
    Goktug, Mehmet Refik
    Yanasma, Zeki Burak
    Hasanzade, Ulviyya
    Evrensel, Turkkan
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [8] Low pan-immune-inflammation-value predicts better chemotherapy response and survival in breast cancer patients treated with neoadjuvant chemotherapy
    Ahmet Bilgehan Şahin
    Erdem Cubukcu
    Birol Ocak
    Adem Deligonul
    Sibel Oyucu Orhan
    Sahsine Tolunay
    Mustafa Sehsuvar Gokgoz
    Sibel Cetintas
    Gorkem Yarbas
    Kazım Senol
    Mehmet Refik Goktug
    Zeki Burak Yanasma
    Ulviyya Hasanzade
    Turkkan Evrensel
    Scientific Reports, 11
  • [9] Pathological predictive factors for tumor response in locally advanced breast carcinomas treated with anthracyclin-based neoadjuvant chemotherapy
    Patel, Trupti
    Gupta, Anuja
    Shah, Manoj
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2013, 9 (02) : 245 - 249
  • [10] Predictors of Survival and Patterns of Recurrence in Breast Cancer Treated with Neoadjuvant Chemotherapy, Surgery, and Radiation
    Keilty, D.
    Namini, S. Nezafat
    Swain, M.
    Maganti, M.
    Cil, T.
    McCready, D. R.
    Cescon, D.
    Amir, E.
    Fleming, R.
    Mulligan, A. M.
    Levin, W.
    Liu, F. F.
    Croke, J. M.
    Fyles, A.
    Koch, C. A.
    Han, K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E24 - E25
12345